Investment Test Drive

AMREX American Growth Fund Series Two E

15 lower fee alternatives found

FeeX scanned the market for similar funds with lower fees and better past returns
Show results with
Investing
$
  YOU ASKED ABOUT FEATURED ALTERNATIVE ? ALTERNATIVE
Fund AMREX American Growth Fund Series Two E FIBG Credit Suisse FI Enhanced Big Cap Gr ETN VUG Vanguard Growth ETF  
Similarity
?
100% 94% 85%
Annual Fees
?
$944.41
(8.94% Exp. Ratio)
$5.28
(0.05% Exp. Ratio)
$8.45
(0.08% Exp. Ratio)
Future Est. Balance in 30 yrs
Assuming 5.64% annual return
$3,122.54 $51,069.67 $50,611.81
Est. savings over 30 yrs +$47,947.13 +$47,489.27
Return
As of 12/31/16
1 YR RETURN -8.76%
3 YR -1.91%
5 YR 4.24%
10 YR --
1 YR RETURN 8.49%
3 YR 11.42%
5 YR --
10 YR --
1 YR RETURN 6.13%
3 YR 7.60%
5 YR 14.05%
10 YR 8.14%
Description
The investment seeks growth of capital. The Adviser use a consistent approach to build the fund's security portfolio which is made up primarily of common stocks involved, in at least some way, in the legal cannabis business. It may also invest in securities convertible into common stock in companies involved in at least some way in the legal cannabis business. These securities may be issued by large companies and also small and mid-sized companies, Micro Cap and REITs. The legal cannabis business does not need to be the sole focus point of a company for Series Two to invest in it nor does it need to account for a majority of its overall revenues.
The investment seeks to approximate the return that might be available through a leveraged “long” investment strategy in the components of the index. The ETNs are medium-term notes of Credit Suisse AG (“Credit Suisse”), the return on which is linked to the performance of the Russell 1000® Growth Index Total Return (the “index”) on a leveraged basis. A leveraged “long” investment strategy involves the practice of borrowing money from a third party lender at an agreed-upon rate of interest and using the borrowed money together with investor capital to purchase assets (e.g., equity securities).
The investment seeks to track the performance of a benchmark index that measures the investment return of large-capitalization growth stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Growth Index, a broadly diversified index predominantly made up of growth stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Join FeeX to view all alternatives, get more data and filtering options, and be able to automatically scan all your investments for lower fee replacements.

It's free!

The fees, balance and savings information above are estimated numbers, based on the data FeeX had at the day of publication, but may not be accurate due to incomplete or erroneous data.

The best choice is based on a combined analysis of lowest fees and highest similarity to the original fund.

Similarity

FeeX's similarity algorithm analyzes over 15 investment characteristics like investment category, asset allocation, strategy, geographical allocation and more. FeeX gives each its own weight and calculates the similarity of any two investments based on a scale of 0 to 100%. Funds with a similarity ranking of 85% and higher are considered "similar".

Yes, funds and ETFs charge fees

Deep within every fund you own lies a hidden fee called expense ratio. It takes away a set % of your savings each and every year. It can often be easily reduced by switching to similar investments with lower expense ratios.

+

Your Feedback has been sent successfully!